Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Equity (2016 - 2025)

Historic Return on Equity for Nephros (NEPH) over the last 15 years, with Q3 2025 value amounting to 0.15%.

  • Nephros' Return on Equity rose 2700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.01% for FY2024, which is 1900.0% up from last year.
  • Latest data reveals that Nephros reported Return on Equity of 0.15% as of Q3 2025, which was up 2700.0% from 0.14% recorded in Q2 2025.
  • Nephros' 5-year Return on Equity high stood at 0.15% for Q3 2025, and its period low was 0.31% during Q2 2023.
  • Its 5-year average for Return on Equity is 0.14%, with a median of 0.17% in 2024.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -2000bps in 2023, then skyrocketed by 3000bps in 2025.
  • Over the past 5 years, Nephros' Return on Equity (Quarter) stood at 0.19% in 2021, then plummeted by -63bps to 0.31% in 2022, then skyrocketed by 41bps to 0.18% in 2023, then soared by 105bps to 0.01% in 2024, then soared by 1481bps to 0.15% in 2025.
  • Its Return on Equity was 0.15% in Q3 2025, compared to 0.14% in Q2 2025 and 0.09% in Q1 2025.